Evommune Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Evommune Inc
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
/ 
Others were interested in
Frequently asked questions
To buy Evommune Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Evommune Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Evommune Inc is EVMN:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Evommune Inc has its primary listing on New York Stock Exchange. You can trade Evommune Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Evommune Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Evommune Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Evommune Inc.